Citeline-Pharma-RD-Annual-Review-2011

Citeline-Pharma-RD-Annual-Review-2011

ID:41331146

大小:1.87 MB

页数:12页

时间:2019-08-22

Citeline-Pharma-RD-Annual-Review-2011_第1页
Citeline-Pharma-RD-Annual-Review-2011_第2页
Citeline-Pharma-RD-Annual-Review-2011_第3页
Citeline-Pharma-RD-Annual-Review-2011_第4页
Citeline-Pharma-RD-Annual-Review-2011_第5页
资源描述:

《Citeline-Pharma-RD-Annual-Review-2011》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、PharmaR&DAnnualReview201111ayisthetimewhenCitelineDrugIntelligence’sAnnualReviewoftrendsinpharmaceuticalR&DisMtraditionallyconducted.Itisausefulopportunitytopauseandreflectonhowtheindustryiscontinu-ingtoevolve,andisalsothetimewhenwetaketheannualsnapshotofourd

2、atawhichprovidesanewtimepointforourTrendsdatamoduleinoneofourdatabaseproducts,Pharmaprojects.Inthisarticle,weexaminethedatafor2011,lookathowithaschangedsince2010,andtrytoputtheinformationintosomesortofcontext.Someofthekeypointscoveredinthisreportinclude:•Grow

3、thofoverallR&Dpipelineflat•Fewnovelnewactivesubstanceslaunchedinpastyear•13%growthindrugsatPhaseIIIstatus•Pfizerholdspositionascompanywithmostdrugsindevelopment•Cancertakes28%sliceofR&Dpie•Pooryearfornewly-identifieddrugtargetsOverallDeclineinTOTalnumberOfacT

4、iveDrugsThetotalnumberofActivedrugscurrentlyreportedontheSoshouldwebeconcernedatallaboutthisapparenttaperingdatabaseisalmostunchangedfor2011,withthefigureofoff?InayearwhichhasseenmoreR&Djoblossesand9,713representingasmallbutinsignificantdecline(0.2%)faltering

5、recoveryinmanyoftheworld’seconomies,itisfromthe2010numberof9,737.Thiswouldappeartocon-probablyacomfortingsignthatthenumberofdrugsinfirmatrend,thebeginningsofwhichwereseenlastyear,developmenthasmore-or-lessheldup.Asweshallseeofaplateauingoffthelonger-termtrend

6、ofyear-on-yearwhenwecometodissecttheR&Dlandscapemoreclosely,increases.Figure1includesthetotalsreportedatthistimetherearesomeencouragingsignsregardingthequality,ifeachyearforeveryyearsince2001,andclearlyshowsthatnotthequantity,ofthedevelopmentpipeline.Butbefor

7、ethetrendformostofthepastdecadewasofslowannualmovingtothis,let’stakealookatthesuccessstoriesofgrowth(thestepincreasefrom2007-2008canbeattrib-2010–thenewactivesubstanceswhichmadetheirmarketutedtothebringingtogetherofdrugdatafromouroriginaldebutduringtheyear.da

8、tabasewiththatfromthethennewly-acquiredCitelinedatabaseofclinicaltrials,TrialTrove).Thosewhofollowthisfiguremorecloselyduringthecourseoftheyearmayhavefigure1:Totalsizeofthepipeline2001-20

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。
相关文章
更多
相关标签